Institute Of Medicine On 510(k) Review Program: Dump It
This article was originally published in The Gray Sheet
The Institute of Medicine committee charged with reviewing FDA's 510(k) device pre-market review program is urging the agency to ditch the 35-year-old program and start fresh.
You may also be interested in...
Sen. Al Franken, D-Minn., who has championed key device regulatory reform changes favoring the medtech industry that are now law, will step down from his post, following newly revealed charges of sexual harassment by a former congressional staffer in 2006.
Consultant and Food & Drug Law Institute Chair Sheila Hemeon-Heyer said it is time to remove the substantial equivalence mandate from the 510(k) program at the FDLI annual conference April 20. “The Gray Sheet” spoke to Hemeon-Heyer and CDRH Director Jeffrey Shuren about the idea.
Newly appointed IOM president is a Duke chancellor and Medtronic board member. Quest Diagnostics makes executive suite changes. Telemedicine firm Advanced ICU Care names chairman and CEO. More people briefs.